Clinical Trial Update: A Study of GFH018 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of GFH018 in patients with advanced solid tumors completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• GFH018 (GFH018)

Snippet

Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2024-03-01